Afghan Acting Health Minister says country wants to boost immunization access

NewsGuard 100/100 Score

Reuters featured an interview with Afghanistan's Acting Health Minister Suraya Dalil on the sidelines of the World Health Assembly in Geneva. "Afghanistan, whose government is fighting a worsening insurgency that has dragged on for nearly a decade since the U.S.-backed overthrow of the Taliban, is also plagued by poverty, malnutrition and corruption," Reuters writes, adding that the government and donors together spend "barely" $10 per person on health annually.

Though Afghanistan vaccinated nearly 83 percent of children against diphtheria, tetanus and pertussis in 2009, compared with 31 percent in 2000, the country still has the second highest child mortality rate in the world, with one in five Afghan children dying before age five, according to a WHO report released last week, Reuters reports. Afghanistan will seek help for funding pneumococcal pneumonia and rotavirus diarrhea vaccines from GAVI Alliance, Dalil told Reuters. "Tens of thousands of lives will be saved ... The government of Afghanistan will co-finance this. That will show our political commitment," she said (Nebehay, 5/17).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    MMR vaccine slashes antibiotic use in toddlers: Nordic study shines light on broader benefits